Literature DB >> 8894264

Mortality, place and mode of death and reinfarction during a period of 5 years after acute myocardial infarction in diabetic and non-diabetic patients.

J Herlitz1, A Bång, B W Karlson.   

Abstract

We describe the prognosis during a 5-year follow-up of 858 consecutive patients with confirmed acute myocardial infarction (AMI), of which 97 (11%) had a history of diabetes mellitus. Diabetic patients had a 5-year mortality of 72% versus 50% for non-diabetic patients (p < 0.001). In a multivariate analysis considering age, sex, diabetes and a history of cardiovascular disease, diabetes was an independent predictor of death (p < 0.001) together with age (p < 0.001), previous AMI (p < 0.001) and a history of congestive heart failure (p < 0.05). Among diabetic patients, 55% developed a reinfarction versus 22% among non-diabetic patients (p < 0.001). Mode and place of death appeared to be similar in diabetic and non-diabetic patients.

Entities:  

Mesh:

Year:  1996        PMID: 8894264     DOI: 10.1159/000177131

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  4 in total

1.  Diabetes and stress hyperglycemia in the intensive care unit: outcomes after cardiac surgery.

Authors:  Roma Y Gianchandani; Nazanene H Esfandiari; Jonathan W Haft; Richard L Prager; Rodica Pop-Busui
Journal:  Hosp Pract (1995)       Date:  2012-04

2.  Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome.

Authors:  Alireza Esteghamati; Mehrshad Abbasi; Manouchehr Nakhjavani; Abbas Yousefizadeh; Amelita P Basa; Hamid Afshar
Journal:  Cardiovasc Diabetol       Date:  2006-07-17       Impact factor: 9.951

Review 3.  Atypical presentation of acute and chronic coronary artery disease in diabetics.

Authors:  Hadi Ar Hadi Khafaji; Jassim M Al Suwaidi
Journal:  World J Cardiol       Date:  2014-08-26

4.  Decision models in type 2 diabetes mellitus: A systematic review.

Authors:  Jiayu Li; Yun Bao; Xuedi Chen; Limin Tian
Journal:  Acta Diabetol       Date:  2021-06-03       Impact factor: 4.280

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.